Weekly reads: odd FDA PRP warning, H3.3 & CTCF, Iowa AG gets $2.5M on stem cell clinic, Colossal Biosciences
Professor Paul Knoepfler, Ph.D.
Platelet-rich plasma or PRP is a regenerative product that has grown in popularity. The literature on clinical applications of PRP is all over the place. Whether it works or not for any particular application is unclear to me. Many orthopedists seem enthused about it. I haven’t seen any major adverse events linked to PRP. PRP […] The post Weekly reads: odd FDA PRP warning, H3.3 & CTCF, Iowa AG gets $2.5M on stem cell clinic, Colossal Biosciences appeared first on The Niche .